Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients

BACKGROUND: Metformin is proposed to have chemopreventive effect of various cancer currently. However, the anti-cancer effect of metformin for diabetic patients with hepatocellular carcinoma (HCC) undergoing liver resection remains unclear. The aim of our cohort study was to assess whether metformin...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:PLoS One
Main Authors: Cho, Wei-Ru, Wang, Chih-Chi, Tsai, Meng-Yun, Chou, Chen-Kai, Liu, Yueh-Wei, Wu, Yi-Ju, Lin, Ming-Tsung, Chen, Kuang-Den, Chuang, Ching-Hui, Huang, Pao-Yuan, Hu, Tsung-Hui, Tsai, Ming-Chao
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2021
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7932176/
https://ncbi.nlm.nih.gov/pubmed/33661912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247231
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים